{"id":37878,"date":"2013-08-09T15:57:14","date_gmt":"2013-08-09T19:57:14","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=news&p=37878"},"modified":"2013-08-09T15:57:14","modified_gmt":"2013-08-09T19:57:14","slug":"the-guidelines-are-dead-long-live-the-guidelines","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2013\/08\/09\/the-guidelines-are-dead-long-live-the-guidelines\/","title":{"rendered":"The Guidelines are Dead. Long Live the Guidelines."},"content":{"rendered":"

Following the recent surprising announcement\u00a0<\/a>that the National Heart, Lung, and Blood Institute would no longer issue guidelines, leaders of the\u00a0American Heart Association (AHA) and the American College of Cardiology (ACC) have now announced that are “officially assuming the\u00a0joint governance, management and public distribution” of the enormously influential cardiovascular prevention guidelines,\u00a0including the much-delayed and much-anticipated hypertension and cholesterol guidelines (formerly known as JNC 8 and ATP IV). The ACC and AHA will also assume responsibility for guidelines on\u00a0cardiovascular risk assessment, cardiovascular lifestyle interventions, and obesity.<\/p>\n

In an editorial published in\u00a0Circulation<\/a><\/em>\u00a0and the\u00a0Journal of the American College of Cardiology<\/a><\/em>, leaders of the NHLBI, AHA, and ACC provide a little more information on how the new model will work. One important announcement, that “all chairs and members of the current writing panels have been invited to continue to work together with the ACC and AHA to finalize the guidelines,” might indicate that the hypertension and cholesterol guidelines could see the light of day in the not-too-far-distant future. In June, the NHLBI’s\u00a0Michael Lauer\u00a0expressed<\/a>\u00a0confidence that these guidelines would appear in less than a year, but the AHA said that no timeline had yet been established.<\/p>\n

More generally, the editorial states that the joint ACC\/AHA Task Force on Practice Guidelines “will provide oversight and staff support, with NHLBI supporting further systematic evidence review as needed.”\u00a0In addition, other “stakeholder organizations” who had been involved in the NHLBI’s efforts “will also be engaged” in the new process, according to the editorial.<\/p>\n

Prior to the NHLBI announcement in June, the fate of the hypertension and cholesterol guidelines, both of which had been delayed for many years, had been the subject of widespread rumor, frustration, and criticism. In the statement published in June on the NHLBI website<\/a>,\u00a0NHLBI director Garry Gibbons wrote\u00a0<\/a>that \u201cthe landscape for guidelines development has changed dramatically. More effective strategies and clinical evidence are available to clinicians and patients.\u201d He cited two reports from the Institute of Medicine (IOM) \u201cthat established new \u2018best practice\u2019 standards for generating systematic evidence reviews and developing clinical practice guidelines. The reports underscore that these are two distinct, yet related, activities that require careful intersection and coordination.\u201d<\/p>\n

Some observers also believe that the backlash against the U.S. Preventive Services Task Force\u2019s mammography guidelines prompted the NIH and public officials to avoid making controversial recommendations.<\/p>\n

 <\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Following the recent surprising announcement\u00a0that the National Heart, Lung, and Blood Institute would no longer issue guidelines, leaders of the\u00a0American Heart Association (AHA) and the American College of Cardiology (ACC) have now announced that are “officially assuming the\u00a0joint governance, management and public distribution” of the enormously influential cardiovascular prevention guidelines,\u00a0including the much-delayed and much-anticipated hypertension […]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7],"tags":[431,476,210,595,454,932],"class_list":["post-37878","post","type-post","status-publish","format-standard","hentry","category-general","category-prevention","tag-acc","tag-aha","tag-cholesterol","tag-guidelines","tag-hypertension","tag-nhlbi"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/37878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=37878"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/37878\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=37878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=37878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=37878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}